Tumor necrosis factor-α in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment

Mediators of Inflammation

Volumn 2006, Issue , 2006, Pages

  Fredriksson, Lars ^a   Alstergren, Per ^a   Kopp, Sigvard ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CELECOXIB; DICLOFENAC; GLUCOCORTICOID; IBUPROFEN; KETOPROFEN; METHOTREXATE; METHYLPREDNISOLONE ACETATE; NABUMETONE; NAPROXEN; PREDNISOLONE; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; MOUTH; MYOFASCIAL PAIN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SYNOVIAL FLUID; SYNOVIAL FLUID LEVEL; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDER; TREATMENT OUTCOME; ARTHRITIS; FACE PAIN; INTRAARTICULAR DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING;

ARTHRITIS; FACIAL PAIN; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRA-ARTICULAR; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SYNOVIAL FLUID; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845871438     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/MI/2006/59425     Document Type: Article

References (23)

1. P J Barnes Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clinical Science 1998 94 6 557 572
2. S Cuzzocrea salvator@unime.it E Ayroldi R Di Paola Role of glucocorticoid-induced TNF receptor family gene (GITR) in collagen-induced arthritis. FASEB Journal 19 10 2005 1253 1265
3. I K Campbell D S Piccoli M J Roberts K D Muirden J A Hamilton Effects of tumor necrosis factor α and β on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis and Rheumatism 33 4 1990 542 552
4. J Neidel M Schulze J Lindschau Association between degree of bone-erosion and synovial fluid-levels of tumor necrosis factor α in the knee-joints of patients with rheumatoid arthritis. Inflammation Research 44 5 1995 217 221
5. S Nordahl silvi.nordahl@swipnet.se P Alstergren S Kopp Tumor necrosis factor-alpha in synovial fluid and plasma from patients with chronic connective tissue disease and its relation to temporomandibular joint pain. Journal of Oral and Maxillofacial Surgery 58 5 2000 525 530
6. S Rosengren G S Firestein D L Boyle dboyle@ucsd.edu Measurement of inflammatory biomarkers in synovial tissue extracts by enzyme-linked immunosorbent assay. Clinical and Diagnostic Laboratory Immunology 10 6 2003 1002 1010
7. R Beyaert W Fiers A R Mire-Sluis R Thorpe Tumor necrosis factor and lymphotoxin. Cytokines Academic Press London, UK 1998 335 360
8. C Haworth F M Brennan D Chantry M Turner R N Maini M Feldmann Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-α European Journal of Immunology 21 10 1991 2575 2579
9. F Q Cunha S Poole B B Lorenzetti S H Ferreira The pivotal role of tumour necrosis factor α in the development of inflammatory hyperalgesia. British Journal of Pharmacology 107 3 1992 660 664
10. L R Watkins E P Wiertelak L E Goehler K P Smith D Martin S F Maier Characterization of cytokine-induced hyperalgesia. Brain Research 654 1 1994 15 26
11. A A van de Loo O J Arntz A C Bakker P LE van Lent M J Jacobs W B van den Berg Role of interleukin 1 in antigen-induced exacerbations of murine arthritis. American Journal of Pathology 146 1 1995 239 249
12. J P Okeson J P Okeson Differential diagnosis and management considerations of temporomandibular disorders. Orofacial Pain - Guidelines for Assessment, Diagnosis and Management Quintessence Carol Stream, Ill 1996 113 184
13. H Isselée A De Laat Antoon.DeLaat@med.kuleuven.ac.be K Bogaerts R Lysens Short-term reproducibility of pressure pain thresholds in masticatory muscles measured with a new algometer. Journal of Orofacial Pain 12 3 1998 203 209
14. L Fredriksson lars.fredriksson@ofa.ki.se P Alstergren S Kopp Absolute and relative facial pressure-pain thresholds in healthy individuals. Journal of Orofacial Pain 14 2 2000 98 104
15. L Fredriksson lars.fredriksson@ofa.ki.se P Alstergren S Kopp Pressure pain thresholds in the craniofacial region of female patients with rheumatoid arthritis. Journal of Orofacial Pain 17 4 2003 326 332
16. P Alstergren per.alstergren@ofa.ki.se S Kopp E Theodorsson Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1β and serotonin. Acta Odontologica Scandinavica 57 1 1999 16 22
17. P Alstergren S Kopp Pain and synovial fluid concentration of serotonin in arthritic temporomandibular joints. Pain 72 1-2 1997 137 143
18. S Kopp S Akerman M Nilner Short-term effects of intra-articular sodium hyaluronate, glucocorticoid, and saline injections on rheumatoid arthritis of the temporomandibular joint. Journal of Craniomandibular Disorders 5 4 1991 231 238
19. P Alstergren A Appelgren B Appelgren S Kopp T Lundeberg E Theodorsson The effect on joint fluid concentration of neuropeptide Y by intra-articular injection of glucocorticoid in temporomandibular joint arthritis. Acta Odontologica Scandinavica 54 1 1996 1 7
20. L Fredriksson lars.fredriksson@ofa.ki.se P Alstergren S Kopp Serotonergic mechanisms influence the response to glucocorticoid treatment in TMJ arthritis. Mediators of Inflammation 2005 4 2005 194 201
21. J-M Dayer B Beutler A Cerami Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E 2 production by human synovial cells and dermal fibroblasts. Journal of Experimental Medicine 162 6 1985 2163 2168
22. F M Brennan A Jackson D Chantry R Maini M Feldmann Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. The Lancet 334 8657 1989 244 247
23. F S Di Giovine G Nuki G W Duff Tumour necrosis factor in synovial exudates. Annals of the Rheumatic Diseases 47 9 1988 768 772